68 related articles for article (PubMed ID: 7332440)
21. Prolactin and somatomedin in hypopituitary patients with "catch up" growth following operations for craniopharyngioma.
Kenny FM; Guyda HJ; Wright JC; Friesen HG
J Clin Endocrinol Metab; 1973 Feb; 36(2):378-80. PubMed ID: 4683190
[No Abstract] [Full Text] [Related]
22. Influence of tumor location on the presentation and evolution of craniopharyngiomas.
Meuric S; Brauner R; Trivin C; Souberbielle JC; Zerah M; Sainte-Rose C
J Neurosurg; 2005 Nov; 103(5 Suppl):421-6. PubMed ID: 16302613
[TBL] [Abstract][Full Text] [Related]
23. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
Karavitaki N; Brufani C; Warner JT; Adams CB; Richards P; Ansorge O; Shine B; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2005 Apr; 62(4):397-409. PubMed ID: 15807869
[TBL] [Abstract][Full Text] [Related]
24. Outcome in children with normal growth following removal of a craniopharyngioma.
Blethen SL; Weldon VV
Am J Med Sci; 1986 Jul; 292(1):21-4. PubMed ID: 3717202
[TBL] [Abstract][Full Text] [Related]
25. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident.
Pervanidou P; Kolaitis G; Charitaki S; Margeli A; Ferentinos S; Bakoula C; Lazaropoulou C; Papassotiriou I; Tsiantis J; Chrousos GP
Psychoneuroendocrinology; 2007; 32(8-10):991-9. PubMed ID: 17825995
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin does not regulate the GH response to insulin-induced hypoglycaemia in children but could be involved in the regulation of cortisol secretion.
Huber J; Reiterer EE; Sudi K; Gallistl S; Friedl K; Weinhandl G; Aigner R; Borkenstein MH
Clin Endocrinol (Oxf); 2007 Jan; 66(1):143-7. PubMed ID: 17201814
[TBL] [Abstract][Full Text] [Related]
27. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
[TBL] [Abstract][Full Text] [Related]
29. [Excessive growth and growth hormone deficiency after treatment for craniopharyngioma].
López Siguero JP; García García E; Martínez-Aedo MJ; Martínez Valverde A
An Esp Pediatr; 2000 Jul; 53(1):64-6. PubMed ID: 10998409
[TBL] [Abstract][Full Text] [Related]
30. Modified orbitozygomatic craniotomy for craniopharyngioma resection in children.
Golshani KJ; Lalwani K; Delashaw JB; Selden NR
J Neurosurg Pediatr; 2009 Oct; 4(4):345-52. PubMed ID: 19795966
[TBL] [Abstract][Full Text] [Related]
31. Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain.
Sorva R
Acta Paediatr Scand; 1988 Jul; 77(4):587-92. PubMed ID: 3394513
[TBL] [Abstract][Full Text] [Related]
32. [Craniopharyngioma: renewed growth after the operation in spite of somatotropic hormone deficiency].
Rosenberg D; David L; Bertrand J; Ruitton-Ugliengo A; Lapras C; Picot C; Monnet P
Lyon Med; 1970 Apr; 223(16):847-57. PubMed ID: 5446108
[No Abstract] [Full Text] [Related]
33. Rapid changes in somatomedin activity during insulin-induced hypoglycemia: possible release of an inhibitory factor.
Hill DJ; Potter JM; Cullen DR; Milner RD
J Clin Endocrinol Metab; 1981 Aug; 53(2):439-42. PubMed ID: 7019232
[TBL] [Abstract][Full Text] [Related]
34. [EEg changes after removal of craniopharyngiomas in children].
Grindel' OM; Bragina NN; Galkina NS; Boldyreva GN; Khukhlaeva EA
Zh Vopr Neirokhir Im N N Burdenko; 1987; (5):25-30. PubMed ID: 3425089
[TBL] [Abstract][Full Text] [Related]
35. Excessive growth in a child with craniopharyngioma and growth hormone deficiency.
Wit JM; Schuitema-Dijkstra A; van Buul-Offers S; Opmeer F; Van den Brande JL
Eur J Pediatr; 1988 Aug; 147(6):658-61. PubMed ID: 3181208
[TBL] [Abstract][Full Text] [Related]
36. Craniopharyngioma: endocrine sequelae of treatment.
Sklar CA
Pediatr Neurosurg; 1994; 21 Suppl 1():120-3. PubMed ID: 7841071
[TBL] [Abstract][Full Text] [Related]
37. Sulfation factor (somatomedin): an explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors.
Finkelstein JW; Kream J; Ludan A; Hellman L
J Clin Endocrinol Metab; 1972 Jul; 35(1):13-7. PubMed ID: 4113389
[No Abstract] [Full Text] [Related]
38. Prolactin and somatomedin studies in the syndrome of growth hormone-independent growth.
Gluckman PD; Holdaway IM
Clin Endocrinol (Oxf); 1976 Sep; 5(5):545-9. PubMed ID: 991434
[TBL] [Abstract][Full Text] [Related]
39. [Somatomedin, transferrin and growth regulation in children].
Donnadieu M; Schimpff RM; Garnier P; Chaussain JL; Job JC
Pathol Biol (Paris); 1980 Jun; 28(6):373-4. PubMed ID: 6994042
[No Abstract] [Full Text] [Related]
40. Growth arrest despite growth hormone replacement, post-craniopharyngioma surgery.
DeVile CJ; Hayward RD; Neville BG; Grant DB; Stanhope R
J R Soc Med; 1995 Apr; 88(4):227P-228P. PubMed ID: 7745571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
